Notch-based gene signature for predicting the response to neoadjuvant chemotherapy in triple-negative breast cancer

被引：0
|
作者：
Mohamed Omar
Pier Vitale Nuzzo
Francesco Ravera
Sara Bleve
Giuseppe Nicolò Fanelli
Claudio Zanettini
Itzel Valencia
Luigi Marchionni
机构：
[1] Weill Cornell Medicine,Department of Pathology and Laboratory Medicine
[2] Dana Farber Cancer Institute,Department of Internal Medicine
[3] University of Genoa,Department of Medical Oncology
[4] IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”,First Division of Pathology, Department of Translational Research and New Technologies in Medicine and Surgery
[5] University of Pisa,undefined
来源：
Journal of Translational Medicine | / 21卷
关键词：
Triple negative breast cancer; Neoadjuvant chemotherapy; Gene signature; Notch signaling pathway; Prediction of therapeutic response;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Notch-based gene signature for predicting the response to neoadjuvant chemotherapy in triple-negative breast cancer
    Omar, Mohamed
    Nuzzo, Pier Vitale
    Ravera, Francesco
    Bleve, Sara
    Fanelli, Giuseppe Nicolo
    Zanettini, Claudio
    Valencia, Itzel
    Marchionni, Luigi
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2023, 21 (01)
  • [2] A gene signature predicts response to neoadjuvant chemotherapy in triple-negative breast cancer patients
    Zheng, Tianzhi
    Pang, Zhiyuan
    Zhao, Zhao
    [J]. BIOSCIENCE REPORTS, 2019, 39
  • [3] Gene signature-based prediction of triple-negative breast cancer patient response to Neoadjuvant chemotherapy
    Zhao, Yanding
    Schaafsma, Evelien
    Cheng, Chao
    [J]. CANCER MEDICINE, 2020, 9 (17): : 6281 - 6295
  • [4] Histomorphological Factors Predicting the Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
    Jung, Yoon Yang
    Hyun, Chang Lim
    Jin, Min-Sun
    Park, In Ae
    Chung, Yul Ri
    Shim, Bobae
    Lee, Kyu Ho
    Ryu, Han Suk
    [J]. JOURNAL OF BREAST CANCER, 2016, 19 (03) : 261 - 267
  • [5] Federated learning for predicting histological response to neoadjuvant chemotherapy in triple-negative breast cancer
    du Terrail, Jean Ogier
    Leopold, Armand
    Joly, Clement
    Beguier, Constance
    Andreux, Mathieu
    Maussion, Charles
    Schmauch, Benoit
    Tramel, Eric W.
    Bendjebbar, Etienne
    Zaslavskiy, Mikhail
    Wainrib, Gilles
    Milder, Maud
    Gervasoni, Julie
    Guerin, Julien
    Durand, Thierry
    Livartowski, Alain
    Moutet, Kelvin
    Gautier, Clement
    Djafar, Inal
    Moisson, Anne-Laure
    Marini, Camille
    Galtier, Mathieu
    Balazard, Felix
    Dubois, Remy
    Moreira, Jeverson
    Simon, Antoine
    Drubay, Damien
    Lacroix-Triki, Magali
    Franchet, Camille
    Bataillon, Guillaume
    Heudel, Pierre-Etienne
    [J]. NATURE MEDICINE, 2023, 29 (1) : 135 - 146
  • [6] Federated learning for predicting histological response to neoadjuvant chemotherapy in triple-negative breast cancer
    Jean Ogier du Terrail
    Armand Leopold
    Clément Joly
    Constance Béguier
    Mathieu Andreux
    Charles Maussion
    Benoît Schmauch
    Eric W. Tramel
    Etienne Bendjebbar
    Mikhail Zaslavskiy
    Gilles Wainrib
    Maud Milder
    Julie Gervasoni
    Julien Guerin
    Thierry Durand
    Alain Livartowski
    Kelvin Moutet
    Clément Gautier
    Inal Djafar
    Anne-Laure Moisson
    Camille Marini
    Mathieu Galtier
    Félix Balazard
    Rémy Dubois
    Jeverson Moreira
    Antoine Simon
    Damien Drubay
    Magali Lacroix-Triki
    Camille Franchet
    Guillaume Bataillon
    Pierre-Etienne Heudel
    [J]. Nature Medicine, 2023, 29 : 135 - 146
  • [7] A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients
    Pineda, Begona
    Diaz-Lagares, Angel
    Alejandro Perez-Fidalgo, Jose
    Burgues, Octavio
    Gonzalez-Barrallo, Ines
    Crujeiras, Ana B.
    Sandoval, Juan
    Esteller, Manel
    Lluch, Ana
    Eroles, Pilar
    [J]. CLINICAL EPIGENETICS, 2019, 11 (1)
  • [8] A two-gene epigenetic signature for the prediction of response to neoadjuvant chemotherapy in triple-negative breast cancer patients
    Begoña Pineda
    Angel Diaz-Lagares
    José Alejandro Pérez-Fidalgo
    Octavio Burgués
    Inés González-Barrallo
    Ana B. Crujeiras
    Juan Sandoval
    Manel Esteller
    Ana Lluch
    Pilar Eroles
    [J]. Clinical Epigenetics, 2019, 11
  • [9] Development of Gene Expression-Based Random Forest Model for Predicting Neoadjuvant Chemotherapy Response in Triple-Negative Breast Cancer
    Park, Seongyong
    Yi, Gwansu
    [J]. CANCERS, 2022, 14 (04)
  • [10] A preliminary study on predicting pathological complete response to neoadjuvant chemotherapy in triple-negative breast cancer
    Chen, Xi
    Zhou, Zhiguo
    [J]. CANCER RESEARCH, 2024, 84 (03)
12345